Causal inference in randomized trials with partial clustering
We show that the two randomization schemes resulting in partially clustered trials have the same dependence structure, enabling use of the same statistical methods for estimation and inference of causal effects. Our novel targeted minimum loss-based estimation approach leverages covariate adjustment and machine learning to improve precision and facilitates estimation of a large set of causal effects. In simulations, we demonstrate that targeted minimum loss-based estimation achieves comparable or markedly higher statistical power than common alternatives for these partially clustered designs. Finally, application of targeted minimum loss-based estimation to real data from the SEARCH-IPT trial resulted in 20%-57% efficiency gains, demonstrating the real-world consequences of our proposed approach.ConclusionsPartially clustered trial analysis can be made more efficient by implementing targeted minimum loss-based estimation, assuming care is taken to account for the dependent nature of the observed data.
Authors
- Jane Kabami (ORCID: https://orcid.org/0000-0002-0265-3174)
- Joshua R. Nugent (ORCID: https://orcid.org/0000-0002-4479-9673)
- Laura B. Balzer (ORCID: https://orcid.org/0000-0002-3730-410X)
- Elijah Kakande (ORCID: https://orcid.org/0000-0001-9532-5710)
- Gabriel Chamie (ORCID: https://orcid.org/0000-0002-5860-8081)
- Asiphas Owaraganise (ORCID: https://orcid.org/0000-0002-5594-0310)
- Diane V. Havlir (ORCID: https://orcid.org/0000-0003-0761-3136)
- Moses Robert Kamya (ORCID: https://orcid.org/0000-0001-9106-4234)
Institutions
- Kaiser Permanente (US)
- University of California, San Francisco (US)
- Infectious Diseases Research Collaboration (UG)
- Makerere University (UG)
- University of California, Berkeley (US)
Publication Details
- Journal
- Clinical Trials
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1177/17407745251333779
- Citations
- 1
- Primary Topic
- Advanced Causal Inference Techniques
- Type
- article
- Field-Weighted Citation Impact
- 2.63
Funders
- National Institute of Allergy and Infectious Diseases